Complement Components and its 7 functional categories

Complement refers to a set of serum proteins that cooperates with both the innate and the adaptive immune systems to eliminate blood and tissue pathogens.

Complement Components

Complement components can be classified into seven functional categories:

  1. Initiator complement components: These proteins initiate their respective complement cascades by binding to particular soluble or membrane-bound molecules. Once bound to their activating ligand, they undergo conformational alterations resulting in changes in their biological activity. The C1q complex, Mannose-Binding Lectin (MBL) etc. are examples of initiator complement components.
  2. Enzymatic mediators: Several complement components, (e.g., C1r, C1s, MASP2, and factor B) are proteolytic enzymes that cleave and activate other members of the complement cascade. Some of these proteases are activated by binding to other macromolecules and undergoing a conformational change. Others are inactive until cleaved by another protease enzyme and are thus termed zymogens: proteins that are activated by proteolytic cleavage. The two enzyme complexes that cleave complement components C3 and C5, respectively, are called the C3 and C5 convertases and are of central importance in the complement cascades.
  3. Membrane-binding components or opsonins: Upon activation of the complement cascade, several proteins are cleaved into two fragments, each of which then takes on a particular role. For C3 and C4, the larger fragments, C3b and C4b, serve as opsonins, enhancing phagocytosis by binding to microbial cells and serving as binding targets for phagocytic cells bearing receptors for C3b or C4b.
  4. Inflammatory mediators: Some small complement fragments act as inflammatory mediators. These fragments enhance the blood supply to the area in which they are released, by binding to receptors on endothelial cells lining the small blood vessels and inducing an increase in capillary diameter. They also attract other cells to the site of tissue damage. Because such effects can be harmful in excess, these fragments are called anaphylatoxins, meaning substances that cause anaphylaxis (“against protection”). Examples include C3a, C5a, and C4a.
  5. Membrane attack proteins: The proteins of the membrane attack complex (MAC) insert into the cell membranes of invading microorganisms and punch holes that result in lysis of the pathogen. The complement components of the MAC are C5b, C6, C7, C8, and multiple copies of C9. Membrane attack proteins are most important in lysis of foreign bodies once complement cascade is activated. MAC is the cytolytic end product of the complement cascade; it forms a transmembrane channel, which causes osmotic lysis of the target cell.
  6. Complement receptor proteins: A complement receptor is a receptor of the complement system, a part of the mediated innate immune system. Complement receptors are responsible for detecting pathogens by mechanisms not mediated by antibodies. Receptor molecules on cell surfaces bind complement proteins and signal-specific cell functions. For example, some complement receptors such as CR1 bind to complement components such as C3b on the surface of pathogens, triggering phagocytosis of the C3-bound pathogen. Binding of the complement component C5a to C5aR receptors on neutrophils stimulates neutrophil degranulation and inflammation. Complement receptors are named with “R,” such as CR1, CR2, and C5aR.
  7. Regulatory complement components: Host cells are protected from unintended complement-mediated lysis by the presence of membrane-bound as well as soluble regulatory proteins. These regulatory proteins include factor I, which degrades C3b, and Protectin, which inhibits the formation of the MAC on host cells.

About Author

Photo of author

Sagar Aryal, PhD

Dr. Sagar Aryal is a microbiologist, researcher, and science communicator from Nepal. He is also co-founder and Research Head of the Department of Natural Products at the Kathmandu Research Institute for Biological Sciences (KRIBS), where he leads research on natural product discovery and microbial biodiversity. Dr. Aryal earned his Ph.D. in Microbiology from Tribhuvan University, Kathmandu, Nepal, in 2025, supported by a DAAD Research Grant and a University Grants Commission (UGC) Nepal Ph.D. Fellowship. His research interests include Actinomycetes, Myxobacteria, microbial taxonomy, and natural products, particularly the discovery of bioactive compounds with potential pharmaceutical applications. He isolated and identified Nocardia nepalensis, a novel bacterial species from Nepal, contributing to understanding microbial diversity in the region. Dr. Aryal has published more than 16 research articles in international journals and contributed three book chapters to established academic publications. He has presented scientific research findings and developed international research collaborations through visits to more than 18 countries across Asia, Europe, North America, and Oceania. From 2023 to 2025, he served as the American Society for Microbiology (ASM) Young Ambassador to Nepal. Since December 2025, he has served as an Editorial Board Member of Scientific Reports, a Nature Portfolio journal. In recognition of his scientific contributions, Dr. Aryal received the NAST Science and Technology Youth Award 2025 from the Nepal Academy of Science and Technology. He previously received the Frs. Locke and Stiller Research Award (LSRA) for the 2017-2018 cycle from St. Xavier's College, Kathmandu, and a Nepal Academy of Science and Technology (NAST) Research Grant for 2017-2018. Alongside his scientific career, Dr. Aryal has more than 15 years of experience in blogging, content writing, and search engine optimization (SEO).